注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
OncoSec Medical Inc是一家后期免疫肿瘤学公司。该公司专注于设计、开发和商业化通过电穿孔(EP)提供的基于肿瘤内DNA的疗法,以刺激和增强用于治疗癌症的抗肿瘤免疫反应。其技术平台ImmunoPulse是一种药物设备治疗方式,由肿瘤间EP输送设备组成,例如OncoSec医疗系统(OMS)EP设备。OMS EP设备旨在将质粒DNA编码的药物直接输送到实体瘤中,并促进对癌症的免疫反应。OMS EP设备适用于治疗不同的肿瘤类型,由电脉冲发生器、可重复使用的手柄和一次性涂抹器组成。其候选产品tavokinogene telseplasmid(TAVO)是一种药物设备组合。该药物由一种称为TAVO的质粒结构组成,该结构带有质粒DNA编码的IL-12,并使用其电穿孔设备输送到肿瘤中。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Iacob Mathiesen | 56 | 2011 | Member of Scientific Advisory Board |
Pamela Munster | - | - | Member of Clinical Advisory Board |
Robert H.I. Andtbacka | - | - | Member of Clinical Advisory Board |
Alain Algazi | - | 2018 | Member of Clinical Advisory Board |
Walter John Urba | - | - | Member of Clinical Advisory Board |
Axel Hauschild | - | 2013 | Member of Clinical Advisory Board |
Richard Heller | - | 2011 | Member of Scientific Advisory Board |
Soldano Ferrone | - | 2014 | Member of Scientific Advisory Board |
Julie Shin | - | 2018 | Board Observer |
Georgina Long | - | - | Member of Clinical Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核